ConductScience.org, home

Paper32905276

Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.

Roy S and 7 others. ACS Omega, 2020. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer. Papers, record 32905276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32905276

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.
PubMed
Journal
ACS Omega
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.94
iCite
Revised in PubMed
2023-11-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roy SSonam
2Mohammad TTaj
3Gupta PPreeti
4Dahiya RRashmi
5Parveen SShahnaz
6Luqman SSuaib
7Hasan GMGulam Mustafa
8Hassan MIMd Imtaiyaz

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122684547Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.Int J Colorectal Dis2012https://conductscience.org/library/papers/22684547PubMed
225153718SPHK1 regulates proliferation and survival responses in triple-negative breast cancer.Oncotarget2014https://conductscience.org/library/papers/25153718PubMed
312011102Sphingosine 1-phosphate, a key cell signaling molecule.J Biol Chem2002https://conductscience.org/library/papers/12011102PubMed
422801037Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.Biochim Biophys Acta2013https://conductscience.org/library/papers/22801037PubMed
53036349Vinca alkaloids in the treatment of non-small cell lung cancer.Cancer Treat Rev1987https://conductscience.org/library/papers/3036349PubMed
615623571Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling.J Exp Med2005https://conductscience.org/library/papers/15623571PubMed
725529771Sphingosine kinase 1 enhances the invasion and migration of non-small cell lung cancer cells via the AKT pathway.Oncol Rep2015https://conductscience.org/library/papers/25529771PubMed
830575912LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.Eur Rev Med Pharmacol Sci2018https://conductscience.org/library/papers/30575912PubMed
912970760Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity.Nat Immunol2003https://conductscience.org/library/papers/12970760PubMed
1012527563Epidemiology of lung cancer.Chest2003https://conductscience.org/library/papers/12527563PubMed
1120041830Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells.Drug Metab Lett2009https://conductscience.org/library/papers/20041830PubMed
1230678498Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.Expert Opin Ther Targets2019https://conductscience.org/library/papers/30678498PubMed
1329434892Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways.Oncol Lett2018https://conductscience.org/library/papers/29434892PubMed
1429208982Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.Sci Rep2017https://conductscience.org/library/papers/29208982PubMed
153703465Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs.Oncology1986https://conductscience.org/library/papers/3703465PubMed
162890483Inhibition of Na+-Ca2+ exchange mechanism in cardiac sarcolemmal vesicles by harmaline.Comp Biochem Physiol C Comp Pharmacol Toxicol1987https://conductscience.org/library/papers/2890483PubMed
177491124Genotoxic potential of beta-carbolines: a review.Mutat Res1995https://conductscience.org/library/papers/7491124PubMed
1828352583Peganum harmala L.'s anti-growth effect on a breast cancer cell line.Biotechnol Rep (Amst)2015https://conductscience.org/library/papers/28352583PubMed
1925516793Crystal Structure of Sphingosine Kinase 1 with PF-543.ACS Med Chem Lett2014https://conductscience.org/library/papers/25516793PubMed
2028744400Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.Am J Cancer Res2017https://conductscience.org/library/papers/28744400PubMed

See all 98 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42640499The potential of harmaline on triple negative breast cancer: harmaline-DNA interaction related apoptosis, anti-metastasis, and in silico analysis.Histochem Cell Biol2026https://conductscience.org/library/papers/42640499PubMed
42417936Harmaline and the gut-brain-immune axis: a novel therapeutic avenue in neuroinflammation and ulcerative colitis.Inflammopharmacology2026https://conductscience.org/library/papers/42417936PubMed
41221048Molecular docking and dynamics in protein serine/threonine kinase drug discovery: advances, challenges, and future perspectives.Front Pharmacol2025https://conductscience.org/library/papers/41221048PubMed
41088942Targeting Chemical-induced Hepatocellular Carcinoma: Ameliorative Potential of Natural Compounds with Focus on Beta-carbolines.Mini Rev Med Chem2026https://conductscience.org/library/papers/41088942PubMed
40453822Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1.3 Biotech2025https://conductscience.org/library/papers/40453822PubMed
39766081Serum Metabolomics Study to Screen Potential Biomarkers of Lung Cancer Risk in High Natural Background Radiation Areas of Thailand: A Pilot Study.Cancers (Basel)2024https://conductscience.org/library/papers/39766081PubMed
38931386The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38931386PubMed
38829482Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B.Mol Cell Biochem2025https://conductscience.org/library/papers/38829482PubMed
38531560Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro.Physiol Rep2024https://conductscience.org/library/papers/38531560PubMed
38276008Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38276008PubMed
38234667In vitro pro-apoptotic and anti-metastatic potentials of harmaline-silver containing folate-linked chitosan nano-drug delivery system.Iran J Basic Med Sci2024https://conductscience.org/library/papers/38234667PubMed
36943605Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro.Mol Biol Rep2023https://conductscience.org/library/papers/36943605PubMed
36709362Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses.Sci Rep2023https://conductscience.org/library/papers/36709362PubMed
36402936Photosensitizing properties and subcellular localisation of 3,4-dihydro-β-carbolines harmaline and harmalol.Photochem Photobiol Sci2023https://conductscience.org/library/papers/36402936PubMed
35799611Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target.J Oncol2022https://conductscience.org/library/papers/35799611PubMed
35720007Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing.Front Oncol2022https://conductscience.org/library/papers/35720007PubMed
35630821Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells.Molecules2022https://conductscience.org/library/papers/35630821PubMed
35216066Mutation in the CX3C Motif of G Protein Disrupts Its Interaction with Heparan Sulfate: A Calorimetric, Spectroscopic, and Molecular Docking Study.Int J Mol Sci2022https://conductscience.org/library/papers/35216066PubMed
34885979
Structural Characterization of Ectodomain G Protein of Respiratory Syncytial Virus and Its Interaction with Heparan Sulfate: Multi-Spectroscopic and In Silico Studies Elucidating Host-Pathogen Interactions.
Molecules2021https://conductscience.org/library/papers/34885979PubMed
34737701Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases.Front Pharmacol2021https://conductscience.org/library/papers/34737701PubMed

See all 21 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32905276

GET https://conductscience.org/api/papers/v1/32905276/references?page=2